SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMolten Ventures Regulatory News (MVCT)

Share Price Information for Molten Ventures (MVCT)

Share Price is delayed by 15 minutes
Get Live Data
37.80    0.00 (0.00%)
Bid:
36.80
Ask:
38.80
Spread: 2.00 (5.435%)
Market Cap: £119.60m
MVCT Live PriceLast checked at - London Stock Exchange

Intraday Molten Ventures Share Chart

Directorate change

23 Jan 2024 12:34

Directorate change

Molten Ventures VCT plc (“Company”)23 January 2024LEI: 2138003I9Q1QPDSQ9Z97Directorate Change

The Board of Molten Ventures VCT plc is pleased to announce the appointment of Sally Duckworth as a non-executive director of the Company with effect from 22 January 2024.

As noted in the Chairman’s Statement with the last Annual Report, the Company has undertaken a process to identify suitable non-executive director candidates as part of a board refresh exercise following a period of significant upheaval.

Sally has worked in the financial services sector since 1990 and in the private equity industry since 2000. She qualified as an accountant with Price Waterhouse and has experience in investment banking at J.P. Morgan and in early-stage venture capital at Quester Capital Management. She has been an active angel investor and has held various board and senior operational roles within technology businesses. She is currently chairman of StorMagic Limited, a private IT storage technology business and audit chair of JPMorgan Japanese Investment Trust plc (JFJ). She is also the audit chair for Mobeus Income and Growth 2 VCT plc (MIG), but will be stepping down from the MIG board later in 2024 as part of their succession planning.

The chairman, David Brock, said “We are delighted that Sally has agreed to join the Board of Molten Ventures VCT plc. She has a wealth of highly relevant experience in both the technology sector, in which the Company now invests, and also the VCT sector. My fellow directors and I are greatly looking forward to working with her.”

The Board confirms that no other disclosures need to be made under Listing Rule 9.6.13 in respect of this appointment.

12
Date   Source Headline
1st May 202610:08 amRNSTotal Voting Rights
24th Apr 20267:00 amRNSIssue of Equity
17th Apr 202612:16 pmRNSIssue of Equity
7th Apr 20264:16 pmRNSDirector/PDMR Shareholding
7th Apr 20261:22 pmRNSIssue of Equity
19th Mar 202612:05 pmRNSDividend Declaration
24th Feb 20267:00 amRNSOffer for Subscription - Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSHalf-year Financial Report
7th Oct 202511:31 amRNSPublication of a Prospectus
1st Oct 202510:31 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSIssue of Equity under DRIS
17th Sep 20252:45 pmRNSResult of AGM
19th Jun 20257:00 amRNSFinal Results
1st May 20259:25 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSIssue of Equity
16th Apr 20254:40 pmRNSDirector/PDMR Shareholding
16th Apr 20254:39 pmRNSDirector/PDMR Shareholding
16th Apr 202512:37 pmRNSIssue of Equity
15th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSIssue of Equity
1st Apr 20252:33 pmRNSDirectorate Change
25th Mar 20258:48 amRNSOffer for Subscription – Update
24th Mar 20252:42 pmRNSDirector Declaration
20th Mar 20254:48 pmRNSDividend Declaration
13th Dec 202412:08 pmRNSHalf-year Report updated
12th Dec 20247:00 amRNSHalf-year Report
11th Oct 202412:20 pmRNSOffer for Subscription
1st Oct 20249:43 amRNSTotal Voting Rights
26th Sep 20241:03 pmRNSIssue of Equity
9th Sep 202411:49 amRNSIntention to launch a fundraising offer
4th Sep 20243:33 pmRNSResult of AGM
2nd Sep 202410:05 amRNSTotal Voting Rights
16th Aug 20248:15 amRNSIssue of Equity
1st Aug 202411:12 amRNSOffer for Subscription - Update
30th Jul 202410:16 amRNSAnnual Financial Report - NSM upload
29th Jul 20247:00 amRNSFinal Results
18th Jun 20242:44 pmRNSOffer Update
1st May 20244:11 pmRNSPortfolio Update
1st May 20249:36 amRNSTotal Voting Rights
24th Apr 20243:31 pmRNSIssue of Equity
15th Apr 20246:04 pmRNSTransaction in Own Shares
23rd Jan 202412:34 pmGNWDirectorate change
29th Dec 202310:03 amGNWForm 8.3 - [MOLTEN VENTURES PLC - 28 12 2023] - (CGAML)
14th Dec 202312:35 pmGNWHalf-year report
4th Dec 20234:39 pmGNWCorrection: Form 8.3 - MOLTEN VENTURES PLC
29th Nov 20232:05 pmGNWForm 8.3 - MOLTEN VENTURES PLC
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.